Stock listing
A2DMZL Stock Price, News, Filings & Events — Mannkind Corporation
Selected listing: A2DMZL · LS · EUR · DE
This page tracks Mannkind Corporation's A2DMZL:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2DMZL:LS. A2DMZL:LS is the stock-level entry point for investors researching Mannkind Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Mannkind Corporation (MNKD) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
- Ticker
- A2DMZL:LS
- Asset type
- Stock
- Market cap
- $1.27B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Mannkind Corporation A2DMZL:LS stock context
This page tracks Mannkind Corporation's A2DMZL:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2DMZL:LS. A2DMZL:LS is the stock-level entry point for investors researching Mannkind Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Mannkind Corporation (MNKD) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Mannkind Corporation
MiNK Therapeutics Reports Second Quarter 2026 Financial Results and Reports Observations from Randomized Phase 2 Trial of agenT-797 in Ac...
August 13, 2026
MannKind Reports Positive Phase 1b INFLO-1 Results, Demonstrating Safety and Tolerability of Nintedanib DPI and Clinical Validation of It...
July 29, 2026
MannKind to Report Second Quarter Financial Results and Host Conference Call on August 5, 2026
July 28, 2026
MannKind Announces $50 Million Private Placement
July 24, 2026
MannKind Announces FDA Approval of Furoscix ReadyFlow™, the First and Only Autoinjector Delivering IV-Equivalent Diuretic Therapy for the...
July 24, 2026
Mannkind Corporation earnings calls
MannKind Corporation (MNKD) Q2 2026 Earnings Call
August 5, 2026 · Replay with transcript and chapters
MannKind Corporation (MNKD) Q1 2026 Earnings Call
May 6, 2026 · Replay with transcript and chapters
MannKind Corporation (MNKD) Q4 2025 Earnings Call
February 26, 2026 · Replay with transcript and chapters
MannKind Corporation (MNKD) Q3 2025 Earnings Call
November 5, 2025 · Replay with transcript and chapters
MannKind Corporation (MNKD) Q2 2025 Earnings Call
August 6, 2025 · Replay with transcript and chapters
MannKind Corporation (MNKD) Q1 2025 Earnings Call
May 8, 2025 · Replay with transcript and chapters
Research Mannkind Corporation
Mannkind Corporation investor report
Review AI stock analysis and investor report context for A2DMZL:LS.
Mannkind Corporation company profile
View the public company page for Mannkind Corporation on 6ix.
Mannkind Corporation news
Read company news and market updates connected to Mannkind Corporation.
Mannkind Corporation investor events
Find investor webinars, events, and replay context for Mannkind Corporation.
Alternate listings
MNKD:NASDAQ
US · USD
Alternate listing for Mannkind Corporation; the primary context on this page is A2DMZL:LS.
MNKD:BOATS
US · USD
Alternate listing for Mannkind Corporation; the primary context on this page is A2DMZL:LS.
NNFN:GETTEX
DE · EUR
Alternate listing for Mannkind Corporation; the primary context on this page is A2DMZL:LS.
A2DMZL:LSX
DE · EUR
Alternate listing for Mannkind Corporation; the primary context on this page is A2DMZL:LS.
NNFN:TRADEGATE
DE · EUR
Alternate listing for Mannkind Corporation; the primary context on this page is A2DMZL:LS.
NNFN:MUN
DE · EUR
Alternate listing for Mannkind Corporation; the primary context on this page is A2DMZL:LS.
NNFN:BX
CH · CHF
Alternate listing for Mannkind Corporation; the primary context on this page is A2DMZL:LS.
NNFN:DUS
DE · EUR
Alternate listing for Mannkind Corporation; the primary context on this page is A2DMZL:LS.
NNFN:FWB
DE · EUR
Alternate listing for Mannkind Corporation; the primary context on this page is A2DMZL:LS.
NNFN:SWB
DE · EUR
Alternate listing for Mannkind Corporation; the primary context on this page is A2DMZL:LS.